Solas-Lung

_solas - lun_加强了BeamLine和伦敦大学学院（UCL）之间的合作关系，主要项目旨在完成400名患者的首次临床试验，以开发我们的技术以获得监管批准：将_solas - lun_推进到TRL6/7\。伦敦大学学院（UCL）通过10年的突破性研究，支持了癌细胞的红外检测。他们是将solas - lung推向下一阶段的理想临床合作伙伴，并与世界领先的研究人员互补，形成一个全面的团队，以确保项目的成功。

_Solas-Lung_ reinforces a partnership between BeamLine and University College London (UCL) with the primary project aim to complete the 400 patient first in clinic trial required for developing our technology towards regulatory approval: advancing _Solas-Lung_ to TRL6/7\. UCL have supported IR detection of cancerous cells with \>10 years of ground-breaking research. They are the ideal clinical partner to progress _Solas-Lung_ to the next stage, and complement with world leading researchers, to produce a rounded team to ensure project success.